Literature DB >> 29625373

Leptin/Adiponectin ratio as a potential biomarker for metabolic syndrome in patients with schizophrenia.

Vincent Chin-Hung Chen1, Chun-Hsin Chen2, Yi-Hang Chiu2, Tsang-Yaw Lin3, Feng-Chiao Li3, Mong-Liang Lu4.   

Abstract

OBJECTIVE: Leptin and adiponectin are adipokines which have opposing roles in the development of insulin resistance and metabolic syndrome (MetS). Leptin/adiponectin ratio (L/A ratio) has been proposed as a good biomarker for MetS in general population. This study aimed to compare the strength of association between MetS and leptin, adiponectin and L/A ratio, as well as to assess their performance to diagnose MetS in patients with schizophrenia.
METHODS: Patients diagnosed with DSM-IV schizophrenia and under clozapine or olanzapine monotherapy for at least six months were recruited. We used the modified ATP III criteria for Asians to evaluate subjects for a diagnosis of MetS.
RESULTS: We recruited 262 study subjects with schizophrenia, and classified them into those with MetS (n = 87) and those without MetS (n = 175). Leptin level was positively correlated with BMI, waist circumference, and insulin level. Adiponectin level was negatively correlated with most metabolic parameters, except glucose level. L/A ratio was positively correlated with most metabolic parameters, except levels of glucose and HDL-C. Significant gender differences existed in leptin levels, adiponectin levels, and L/A ratio. Without and with adjustment of age and gender, binary logistic regression analysis showed that leptin level, adiponectin level, and L/A ratio were significantly associated with MetS. The area under curve (AUC) of L/A ratio and leptin level for MetS was 0.744 (95% CI = 0.685-0.802) and 0.666 (95% CI = 0.601-0.731). The AUC of adiponectin level for the absence of MetS was 0.717 (95% CI = 0.655-0.780). The discriminative strength of L/A ratio for MetS was better in men than in women.
CONCLUSIONS: The present study results suggest that L/A ratio may be a preferential marker of metabolic syndrome in patients with schizophrenia compared to leptin or adiponectin alone.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adiponectin; Biomarker; Leptin; Metabolic syndrome; Schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 29625373     DOI: 10.1016/j.psyneuen.2018.03.021

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  10 in total

Review 1.  Psychiatric drugs impact mitochondrial function in brain and other tissues.

Authors:  Shawna T Chan; Michael J McCarthy; Marquis P Vawter
Journal:  Schizophr Res       Date:  2019-11-16       Impact factor: 4.939

Review 2.  The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia.

Authors:  Cynthia Yi-An Chen; Kah Kheng Goh; Chun-Hsin Chen; Mong-Liang Lu
Journal:  Front Psychiatry       Date:  2021-01-20       Impact factor: 4.157

3.  Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review.

Authors:  Marius H Sneller; Nini de Boer; Sophie Everaars; Max Schuurmans; Sinan Guloksuz; Wiepke Cahn; Jurjen J Luykx
Journal:  Front Psychiatry       Date:  2021-03-29       Impact factor: 4.157

Review 4.  Emerging Roles of FTO in Neuropsychiatric Disorders.

Authors:  Rui Chang; Zeyi Huang; Size Zhao; Ju Zou; Yukun Li; Sijie Tan
Journal:  Biomed Res Int       Date:  2022-04-26       Impact factor: 3.246

5.  Association of higher plasma leptin levels with HOMA-IR index, high sensitivity C-reactive protein and glycolipid metabolism in patients with chronic schizophrenia: A multi-center cross-sectional study.

Authors:  Zhiwei Liu; Yulong Zhang; Juan Wang; Lei Xia; Yating Yang; Liang Sun; Dapeng Zhang; Wenzheng Li; Xianhu Yao; Rongchun Yang; Yun Liu; Huanzhong Liu
Journal:  Front Psychiatry       Date:  2022-08-25       Impact factor: 5.435

6.  Assessment of vitamin D levels and adipokines mediated obesity among psychiatric patients on treatment and treatment naïve: A comparative cross-sectional study.

Authors:  Linda A Fondjo; Olivia Osei; William K B A Owiredu; Christian Obirikorang; Ebenezer Senu; Ruth Owusu-Antwi; Eugene F J Brefo
Journal:  Health Sci Rep       Date:  2022-10-07

7.  Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial.

Authors:  Chenchen Liu; Dongyu Kang; Jingmei Xiao; Yuyan Huang; Xingjie Peng; Weiyan Wang; Peng Xie; Ye Yang; Jingping Zhao; Renrong Wu
Journal:  Trials       Date:  2021-02-23       Impact factor: 2.279

8.  Effect of personalized moderate exercise training on Wistar rats fed with a fructose enriched water.

Authors:  Julie Dupas; Annie Feray; Anthony Guernec; Morgane Pengam; Manon Inizan; François Guerrero; Jacques Mansourati; Christelle Goanvec
Journal:  Nutr Metab (Lond)       Date:  2018-10-03       Impact factor: 4.169

9.  Adipose tissue dysfunction, inflammation, and insulin resistance: alternative pathways to cardiac remodelling in schizophrenia. A multimodal, case-control study.

Authors:  Emanuele F Osimo; Mark Sweeney; Antonio de Marvao; Alaine Berry; Ben Statton; Benjamin I Perry; Toby Pillinger; Thomas Whitehurst; Stuart A Cook; Declan P O'Regan; E Louise Thomas; Oliver D Howes
Journal:  Transl Psychiatry       Date:  2021-12-06       Impact factor: 6.222

10.  Secondary data analysis investigating effects of marine omega-3 fatty acids on circulating levels of leptin and adiponectin in older adults.

Authors:  J A Rausch; S Gillespie; T Orchard; A Tan; J C McDaniel
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2021-05-24       Impact factor: 3.015

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.